Why Viavi Solutions Stock Fell 6.6% Today

Viavi Solutions (VIAV) is down 6.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is profit-taking rather than a clear new negative company-specific event. Viavi has been a volatile stock after a sharp run tied to AI data-center and network-testing optimism, and today’s drop appears to be a pullback as investors digest earlier gains and the lingering dilution impact from its May stock sale.

Details:

Viavi’s latest quarterly update pointed to continued momentum, with fiscal third-quarter results ahead of expectations and fourth-quarter guidance calling for revenue of $427 million to $437 million and non-GAAP EPS of $0.29 to $0.31.

The company has continued to announce product news in June, including a new validation solution for Ultra Ethernet environments aimed at AI data-center deployments and a PCIe 6.0 testing milestone.

Balance-sheet news has also been supportive recently: Viavi used proceeds from its equity raise to repay its term loan, which helped drive credit-rating upgrades.

With the stock having traded near its 52-week high recently, this could be because traders chose to lock in gains after a strong rally, especially in a name that has shown frequent swings of more than 5% over the past year.

Sources:

VIAVI Solutions Investor Relations, Stock Analysis, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$VIAV Insider Trading Activity

$VIAV insiders have traded $VIAV stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.

Here’s a breakdown of recent trading of $VIAV stock by insiders over the last 6 months:

OLEG KHAYKIN (President & CEO) has made 0 purchases and 10 sales selling 509,712 shares for an estimated $17,843,515.
RICHARD BELLUZZO has made 0 purchases and 3 sales selling 79,943 shares for an estimated $3,493,105.
GARY W STALEY (SVP Global Sales NSE) has made 0 purchases and 7 sales selling 90,069 shares for an estimated $2,289,155.
KEVIN CHRISTOPHER SIEBERT (SVP Gen. Counsel & Secretary) has made 0 purchases and 3 sales selling 29,096 shares for an estimated $1,047,777.
LUKE M SCRIVANICH (SVP General Manager OSP) has made 0 purchases and 3 sales selling 24,594 shares for an estimated $936,356.
DONALD A COLVIN sold 25,000 shares for an estimated $730,750
DOUG GILSTRAP sold 10,000 shares for an estimated $550,000
PAUL MCNAB (EVP, Chief Mktg & Stgy Officer) has made 0 purchases and 3 sales selling 10,916 shares for an estimated $386,328.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive VIAV Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$VIAV Hedge Fund Activity

We have seen 259 institutional investors add shares of $VIAV stock to their portfolio, and 223 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ added 8,681,201 shares (+576.6%) to their portfolio in Q1 2026, for an estimated $288,910,369
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 7,888,249 shares (-70.3%) from their portfolio in Q4 2025, for an estimated $140,568,597
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 5,897,957 shares (-88.4%) from their portfolio in Q1 2026, for an estimated $196,284,008
WELLINGTON MANAGEMENT GROUP LLP removed 5,556,301 shares (-50.5%) from their portfolio in Q1 2026, for an estimated $184,913,697
CAPITAL WORLD INVESTORS removed 4,050,091 shares (-25.9%) from their portfolio in Q1 2026, for an estimated $134,787,028
WHALE ROCK CAPITAL MANAGEMENT LLC added 3,473,152 shares (+inf%) to their portfolio in Q1 2026, for an estimated $115,586,498
FMR LLC added 3,282,361 shares (+548.3%) to their portfolio in Q1 2026, for an estimated $109,236,974

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$VIAV Congressional Stock Trading

Members of Congress have traded $VIAV stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $VIAV stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 05/04, 03/27, 03/09.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$VIAV Analyst Ratings

Wall Street analysts have issued reports on $VIAV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/29/2026

To track analyst ratings and price targets for $VIAV, check out Quiver Quantitative's $VIAV forecast page.

$VIAV Price Targets

Multiple analysts have issued price targets for $VIAV recently. We have seen 6 analysts offer price targets for $VIAV in the last 6 months, with a median target of $62.5.

Here are some recent targets:

Mike Genovese from Rosenblatt set a target price of $70.0 on 06/10/2026
Ryan Koontz from Needham set a target price of $68.0 on 04/30/2026
Mehdi Hosseini from Susquehanna set a target price of $65.0 on 04/30/2026
Andrew Spinola from UBS set a target price of $60.0 on 04/30/2026
Dave Kang from B. Riley Securities set a target price of $53.0 on 04/24/2026
Ruben Roy from Stifel set a target price of $24.0 on 01/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.